Absorption Inhalation insulin is absorbed as quickly as subcutaneously administered rapid-acting insulin analogs and more quickly than subcutaneous regular human insulin.
Onset 0.5 to 1 h (regular). 1 to 1.6 h (NPH). 1 to 2.5 h (lente). 4 to 8 h (ultralente). 10 to 20 min (inhalation).
Peak 4 to 12 h (NPH). 7 to 15 h (lente). 10 to 30 h (ultralente). Max effect approximately 2 h after inhalation.
Duration 8 to 12 h (regular). 24 h (NPH, lente). 20 to 36 h (ultralente). Approximately 6 h (inhalation).
Special Populations Passive cigarette smoking Insulin C max and AUC may be reduced approximately 30% to 20%, respectively.
|
ACE inhibitors, anabolic steroids, clofibrate, disopyramide, fibrates, fluoxetine, guanethidine, MAOIs, oral antidiabetics, propoxyphene, salicylates, sulfinpyrazone, sulfonamide antibiotics, tetracyclines May increase hypoglycemic effects of insulin.
Alcohol, beta-blockers, clonidine, lithium salts May increase or decrease the blood glucose-lowering effect of insulin.
Atypical antipsychotics, corticosteroids, danazol, diazoxide, diltiazem, glucagon, isoniazid, oral contraceptives, phenothiazines, protease inhibitors, somatropin, sympathomimetics, thyroid hormone May decrease hypoglycemic effects of insulin.
Beta-blockers, clonidine, guanethidine, reserpine Signs and symptoms of hypoglycemia may be reduced or absent.
Bronchodilators, other inhaled products May alter the absorption of inhaled human insulin.
Pentamidine May cause hypoglycemia, which may be followed by hyperglycemia.
|